Effects of basal plus prandial insulin regimen on body weight in patients with type 2 diabetes poorly controlled with basal insulin and oral antidiabetic drugs
Effects of basal plus prandial insulin regimen on body weight in patients with type 2 diabetes poorly controlled with basal insulin and oral antidiabetic drugs
[version 1; not peer reviewed]This study was funded by sanofi-aventis U.S. The authors received editorial/writing support in the preparation of this poster provided by Debbi Gorman, PhD, of Excerpta Medica, funded by sanofi-aventis U.S. Corresponding author Denis Raccah is a consultant or speaker in symposia for sanofi-aventis U.S., Novo Nordisk, Eli Lilly, Novartis, and MSD. Authors Ling Gao and Racele Berria are contract employee and employee of sanofi-aventis U.S., respectively.
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
All commenters must hold a formal affiliation as per our Policies. The information that you give us will be displayed next to your comment.
User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.
Use of this website is subject to the F1000 Research Limited (F1000) General Terms and Conditions.
Submission of user comments to this website is subject to additional Terms and Conditions. By clicking "I accept the User Comment Terms and Conditions" before you submit your first comment, you agree to be bound by these conditions every time you submit a comment.
Terms relating to user comments